Thank you for supporting the best outpatient clinical trials of repurposed drugs for COVID-19 treatments.
The COVID-19 Early Treatment Fund (CETF) is administered by Rockefeller Philanthropy Advisors, a 501(c)(3) public charity. All donations to CETF are tax deductible and go exclusively towards funding outpatient trials of the most promising COVID-19 treatments that leverage existing drugs. These trials are taking place at top academic institutions and aim to reduce or eliminate the need for COVID-19 related hospitalizations, so we can safely return to our normal lives without waiting for a vaccine.
Additional payment methods are available to donors interested in contributing $10k or more.